Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04074486 · ClinicalTrials.gov registry record
Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC
A clinical trial, sponsored by BrainScope Company.
- Completed
- Registry status
- 1,318
- Enrollment target
NCT04074486 is a clinical trial that has completed, run by BrainScope Company. The registered enrollment target is 1,318 participants.
The verdict
NCT04074486 has completed, sponsored by BrainScope Company.
- COMPLETED
- Registry status
- 1,318 participants
- Enrollment target
Study Summary
This study is designed to collect data which will be used to associate changes in EEG, neurocognitive performance, eNPC and clinical symptoms in concussion subtypes. The study will recruit males and females, 13-50 years old, from Concussion Centers/Programs, Sports Venues and Emergency Departments (ED) across the country, over an 18-month period (Phase 2, 12 months for Algorithm Development and Norming, and Phase 3, 6 months for Validation).
Interventions
- DEVICE BrainScope Ahead 300iP-O
- DIAGNOSTIC_TEST SCAT5
- DIAGNOSTIC_TEST Near Point Convergence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,318 participants |
| Start Date | 2019-10-02 |
| Est. Completion | 2022-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04074486
The ClinicalTrials.gov registry entry for NCT04074486 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,318 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BrainScope Company, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which BrainScope Ahead 300iP-O is the first listed.
NCT04074486 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04074486 about?
NCT04074486 is a clinical study titled "Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC". This study is designed to collect data which will be used to associate changes in EEG, neurocognitive performance, eNPC and clinical symptoms in concussion subtypes. The study will recruit males and females, 13-50 years old, from Concussion Centers/Programs, Sports Venues and Emergency Departments (...
What is the current status of trial NCT04074486?
This trial is currently completed. The enrollment target is 1,318 participants. The study started on 2019-10-02. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT04074486?
The interventions under investigation include: BrainScope Ahead 300iP-O (DEVICE), SCAT5 (DIAGNOSTIC_TEST), Near Point Convergence (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04074486?
This trial is sponsored by BrainScope Company, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.